FDA Clearance Tracker · P840001-S512
Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117); Int
Last checked: Nov 20, 2026Latest source record: Apr 24, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 24, 2024
Approved
Time to decision
785 days
Received Mar 1, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P840001-S512
- Device name
- Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117); Int
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Mar 1, 2022
- Decided
- Apr 24, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P840001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for the Pain RC SCS System including: 1) the new Inceptiv LT (Model 977117), Intellis Pro (Model 977118), and Inceptiv (Model 977119) implantable neurostimulators; 2) the Neuro Sense closed-loop stimulation feature for Medtronic Vectris SureScan MRI 1x8 Compact Leads (Models 977A260, 977A275, and 977A290 only); 3) updated Differential Target Multiplexed (DTM) SCS user interface (i.e., the DTM programming style, Spine Anatomy View, and DTM templating feature); and 4) a new wireless recharger (Model WR9230).
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.